Inventor
KAPLAN ALAN
21 patents
⚠️ This page may combine multiple inventors who share the name “KAPLAN ALAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DART NEUROSCIENCE CAYMAN LTD
6 patentsUS9150572B2Oct 6, 2015
Substituted naphthyridine and quinoline compounds as MAO inhibitors
DART NEUROSCIENCE CAYMAN LTD2 citations61
US9102674B2Aug 11, 2015
Substituted naphthyridine and quinoline compounds as MAO inhibitors
DART NEUROSCIENCE CAYMAN LTD2 citations61
US9120770B2Sep 1, 2015
Substituted pyridine and pyrazine compounds as PDE4 inhibitors
DART NEUROSCIENCE CAYMAN LTD3 citations60
US9040692B2May 26, 2015
Substituted pyridine and pyrazine compounds as PDE4 inhibitors
DART NEUROSCIENCE CAYMAN LTD2 citations60
US9956213B2May 1, 2018
Substituted naphthyridine and quinoline compounds as MAO inhibitors
DART NEUROSCIENCE CAYMAN LTD0 citations50
US10053467B2Aug 21, 2018
Therapeutic isoxazole compounds
DART NEUROSCIENCE CAYMAN LTD0 citations49
DART NEUROSCIENCE (CAYMAN) LTD
4 patentsUS9708334B2Jul 18, 2017
Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitors
DART NEUROSCIENCE (CAYMAN) LTD2 citations70
US9650349B2May 16, 2017
Therapeutic isoxazole compounds
DART NEUROSCIENCE (CAYMAN) LTD3 citations70
US9675605B2Jun 13, 2017
Substituted naphthyridine and quinoline compounds as MAO inhibitors
DART NEUROSCIENCE (CAYMAN) LTD1 citations61
US9573937B2Feb 21, 2017
Substituted pyridine and pyrazine compounds as PDE4 inhibitors
DART NEUROSCIENCE (CAYMAN) LTD1 citations60